Sept. 12, 2002; Tom Miller, Director of Health Policy Studies. Excerpt: [T]here is little, if any, evidence that health insurers are using or likely to use presymptomatic genetic information in their medical underwriting. Evidence that employers try to obtain, let alone use, such information generally is limited to isolated anecdotes.